1. Academic Validation
  2. FGF/FGFR signaling in health and disease

FGF/FGFR signaling in health and disease

  • Signal Transduct Target Ther. 2020 Sep 2;5(1):181. doi: 10.1038/s41392-020-00222-7.
Yangli Xie # 1 Nan Su # 2 Jing Yang 2 Qiaoyan Tan 2 Shuo Huang 2 Min Jin 2 Zhenhong Ni 2 Bin Zhang 2 Dali Zhang 2 Fengtao Luo 2 Hangang Chen 2 Xianding Sun 2 Jian Q Feng 3 Huabing Qi 4 Lin Chen 5
Affiliations

Affiliations

  • 1 Department of Wound Repair and Rehabilitation Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Research Institute of Surgery, Daping Hospital, Army Medical University, Chongqing, China. [email protected].
  • 2 Department of Wound Repair and Rehabilitation Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Research Institute of Surgery, Daping Hospital, Army Medical University, Chongqing, China.
  • 3 Department of Biomedical Sciences, Texas A&M University College of Dentistry, Dallas, TX, 75246, USA.
  • 4 Department of Wound Repair and Rehabilitation Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Research Institute of Surgery, Daping Hospital, Army Medical University, Chongqing, China. [email protected].
  • 5 Department of Wound Repair and Rehabilitation Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Research Institute of Surgery, Daping Hospital, Army Medical University, Chongqing, China. [email protected].
  • # Contributed equally.
Abstract

Growing evidences suggest that the Fibroblast Growth Factor/FGF receptor (FGF/FGFR) signaling has crucial roles in a multitude of processes during embryonic development and adult homeostasis by regulating cellular lineage commitment, differentiation, proliferation, and Apoptosis of various types of cells. In this review, we provide a comprehensive overview of the current understanding of FGF signaling and its roles in organ development, injury repair, and the pathophysiology of spectrum of diseases, which is a consequence of FGF signaling dysregulation, including cancers and chronic kidney disease (CKD). In this context, the agonists and antagonists for FGF-FGFRs might have therapeutic benefits in multiple systems.

Figures